- Home
- CAR vs NVCR Comparison
CAR vs NVCR Comparison
Compare CAR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAR
- NVCR
- Stock Information
- Founded
- CAR 1946
- NVCR 2000
- Country
- CAR United States
- NVCR Jersey
- Employees
- CAR N/A
- NVCR N/A
- Industry
- CAR Rental/Leasing Companies
- NVCR Medical/Dental Instruments
- Sector
- CAR Consumer Discretionary
- NVCR Health Care
- Exchange
- CAR Nasdaq
- NVCR Nasdaq
- Market Cap
- CAR 3.9B
- NVCR 3.2B
- IPO Year
- CAR N/A
- NVCR 2015
- Fundamental
- Price
- CAR $90.19
- NVCR $26.17
- Analyst Decision
- CAR Buy
- NVCR Buy
- Analyst Count
- CAR 8
- NVCR 5
- Target Price
- CAR $130.71
- NVCR $33.40
- AVG Volume (30 Days)
- CAR 637.5K
- NVCR 1.0M
- Earning Date
- CAR 02-10-2025
- NVCR 02-27-2025
- Dividend Yield
- CAR N/A
- NVCR N/A
- EPS Growth
- CAR N/A
- NVCR N/A
- EPS
- CAR 11.08
- NVCR N/A
- Revenue
- CAR $11,843,000,000.00
- NVCR $577,738,000.00
- Revenue This Year
- CAR N/A
- NVCR $19.13
- Revenue Next Year
- CAR $1.76
- NVCR $5.38
- P/E Ratio
- CAR $8.14
- NVCR N/A
- Revenue Growth
- CAR N/A
- NVCR 14.63
- 52 Week Low
- CAR $65.73
- NVCR $11.70
- 52 Week High
- CAR $176.79
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- CAR 55.27
- NVCR 41.68
- Support Level
- CAR $81.55
- NVCR $25.46
- Resistance Level
- CAR $88.57
- NVCR $27.70
- Average True Range (ATR)
- CAR 3.00
- NVCR 1.29
- MACD
- CAR 1.29
- NVCR -0.82
- Stochastic Oscillator
- CAR 94.61
- NVCR 10.77
About CAR Avis Budget Group Inc.
Avis Budget Group Inc is a provider of automotive vehicle rental and car-sharing services. Its brands include Avis, Budget, and Zipcar. Avis is targeted to serve the premium commercial and leisure segments of the travel industry, while Budget is focused on value-conscious customers. The company operates its own network of rental locations and licenses its brands to franchisees. Zipcar is a car-sharing service that allows members to use the company-owned Zipcar fleet at an hourly rate. The company's largest region by revenue is the Americas.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.